Metrics to compare | 600161 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.0x | 34.6x | −0.4x | |
PEG Ratio | −0.74 | 0.70 | 0.00 | |
Price/Book | 2.1x | 2.2x | 2.6x | |
Price / LTM Sales | 4.1x | 5.6x | 3.0x | |
Upside (Analyst Target) | 50.0% | 33.3% | 46.9% | |
Fair Value Upside | Unlock | 2.5% | 5.3% | Unlock |
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.